Safety and efficacy of glucose–insulin–potassium treatment in coronary artery bypass graft surgery and percutaneous coronary intervention
Open Access
- 11 August 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 21 (5) , 667-676
Abstract
The purpose of this meta-analysis was to evaluate protective effects of glucose–insulin–potassium (GIK) on outcomes after coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). We systematically searched Medline/Pubmed, Elsevier, Embase, Web of Knowledge and Google Scholar. A total of 1206 studies were retrieved during the extensive literature search of all major databases; however, 38 trials reporting the end-point of interest were selected. We performed a pooled analysis of outcomes following PCI: incidence of cardiac arrest [odds ratio (OR) of 0.91; 95% confidence interval (CI): 0.76–1.09; P = 0.3], stroke (OR of 1.71; 95% CI: 0.37–1.37; P = 0.3), cardiogenic shock (OR of 1.02; 95% CI: 0.92–1.14; P = 0.6), reinfarction (OR of 0.95; 95% CI: 0.81–1.14; P = 0.5) and mortality (OR of 1.04; 95% CI: 0.96–1.13; P = 0.3); and following CABG: incidence of atrial fibrillation (OR of 0.86; 95% CI: 0.70–1.05; P = 0.1), incidence of ventricular fibrillation (OR of 0.83; 95% CI: 0.62–1.13; P = 0.2), reinfarction (OR of 0.97; 95% CI: 0.74–1.27; P = 0.8), infection (OR of 1.04; 95% CI: 0.67–1.62; P = 0.8), length of intensive care unit stay (LIS) [standard mean differences (SMD) of −0.27; 95% CI: −0.40 to −0.14; P = 0.000], length of hospital stay (LHS) (SMD of −0.035; 95% CI: −0.12 to −0.05; P = 0.4) and mortality (OR of 0.72; 95% CI: 0.41–1.26; P = 0.2). Our results showed that GIK did not have considerable cardioprotective effects. However, patients undergoing CABG seem to be better responders to GIK therapy compared with patients undergoing PCI. Furthermore, in contrast to CABG, GIK therapy in patients undergoing PCI might be associated with more complications rather than protective effects.Keywords
This publication has 53 references indexed in Scilit:
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary InterventionCirculation, 2011
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsThe Lancet, 2003
- Physiological insulin concentrations protect against ischemia-induced loss of cardiac function in ratsComparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 2002
- ATP Synthesis During Low-Flow IschemiaCirculation, 2000
- Myocardial substrate metabolism influences left ventricular energetics in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 2000
- Increased glycolytic substrate protection improves ischemic cardiac dysfunction and reduces injuryAmerican Heart Journal, 2000
- Influence of glucose, insulin, and potassium on vulnerability to ventricular fibrillation in the canine heart.Circulation Research, 1978
- The glucose hypothesis: Relation to acute myocardial ischaemiaJournal of Molecular and Cellular Cardiology, 1970
- Malaria in Britain.BMJ, 1969
- SERUM-FREE-FATTY-ACIDS AFTER ACUTE MYOCARDIAL INFARCTION AND CEREBRAL VASCULAR OCCLUSIONThe Lancet, 1966